What's New

Biospecimen Tables

07/06/2021 – Primary Diagnosis and Second Malignancy

Recent CCSS Publications

  •  Rodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Chow EJ, Oeffinger KC, Armstrong GT, Ness KK, Kadan-Lottick NS. Longitudinal evaluation of neuromuscular dysfunction in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev, 2021; 30(8):1536-1545.
  • Trendowski MR, Baedke J, Sapkota Y, Travis LB, Zhang X, Charif OE, Wheeler HE, Leisenring W, Robison LL, Hudson MM, Morton L, Oeffinger KC, Howell RM, Armstrong GT, Bhatia S, Dolan ME.  Clinical and genetic risk factors for radiation-associated ototoxicity: a report from the Childhood Cancer Survivor Study and the St. Jude Lieftime cohort. Cancer, 2021; 127(21):4091-4102.
  • Dieffenbach BV, Liu Q, Murphy A, Stein D, Wu N, Madenci A, Leisenring W, Kadan-Lottick N, Christison-Lagay E, Goldsby R, Howell R, Smith S, Oeffinger K, Yasui Y, Armstrong G, Weldon C, Chow E, Weil B.  Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer, 2021; 155:216-226.
  • Krull KR, McDonald A, Goodman P, Vukadinovich C, Ford J, Leisenring WM, Chow E, Robison LL, Armstrong GT.  Impact of the COVID-19 pandemic on a large cohort of adult survivors of childhood cancer. Pediatr Blood Cancer, 2021; 68(11):e29324

Latest results from long-term follow-up study